A Study in Healthy People to Test How 2 Different Formulations of a Combination Treatment (Vicadrostat and Empagliflozin) Are Taken up in the Body and How Food Influences the Amount of the Medicines in the Blood

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 8, 2025

Primary Completion Date

October 22, 2025

Study Completion Date

October 22, 2025

Conditions
Healthy
Interventions
DRUG

vicadrostat / empagliflozin combination 1

vicadrostat / empagliflozin combination 1

DRUG

vicadrostat / empagliflozin 2

vicadrostat / empagliflozin 2

Trial Locations (1)

68167

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY